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In Brief
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predicting sgRNA potency that they
combine with expression strategies to
generate a CRISPR resource for
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multiplexed gene knockout in human
cells. The resource is compared to other
published tools through comparative
multiplexed screens.
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We have combined a machine-learning approach
with other strategies to optimize knockout efficiency
with the CRISPR/Cas9 system. In addition, we have
developed a multiplexed sgRNA expression strategy
that promotes the functional ablation of single genes
and allows for combinatorial targeting. These strate-
gies have been combined to design and construct a
genome-wide, sequence-verified, arrayedCRISPR li-
brary. This resource allows single-target or combina-
torial genetic screens to be carried out at scale in a
multiplexed or arrayed format. By conducting parallel
loss-of-function screens, we compare our approach
to existing sgRNA design and expression strategies.
INTRODUCTION
Genetic screens have played a fundamental role in charting ge-
notype-phenotype interaction maps for a variety of organisms
(Carpenter and Sabatini, 2004). However, confounding factors,
such as non-uniformity in the efficacies of targeting molecules,
have limited the depth to which data from such studies can be in-
terpreted. These problems have been somewhat mitigated for
short hairpin RNA (shRNA)-based gene silencing because, after
several rounds of optimization, experimentally validated
algorithms for selecting potent guide sequences have been
developed (Fellmann et al., 2011; Knott et al., 2014; Pelossof et
al., 2017). Similar approaches have been applied for selecting
Cas9guideRNAs (sgRNAs) for usewith the type II clustered regu-
larly interspaced short palindromic repeats (CRISPR) system,
where large sgRNA potency datasets were used to train predic-
tion algorithms (Chari et al., 2015; Doench et al., 2014, 2016).
However, unlike with mRNA cleavage, Cas9-induced double-
strand breaks (DSBs) leave a genomic scar whose characteris-
ticsdetermine thephenotypic consequencesof targeting a locus.
The distance of the target from the translation start site is anti-
correlated with sgRNA efficacy, probably because N terminus
proximal frameshift mutations (FSMs) are more likely to induce
nonsense-mediated mRNA decay or the production of truncated348 Molecular Cell 67, 348–354, July 20, 2017 ª 2017 The Authors. P
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end joining (NHEJ) was thought to act as the predominant repair
mechanism at Cas9-induced DSBs; this made predicting the
likelihood of an FSM, for a given target, impossible. However,
deep sequencing of these genomic scars has revealed that
some homologous end joining (HEJ) contributes to repair of
Cas9 cleavage events (Bae et al., 2014). Here the frequencies
of specific repair resolutions are dependent on the length, gua-
nine-cytosine (GC) content, and distance from the cut site of
the two DSB-flanking homologous loci, suggesting that these
likelihoods can be estimated. Finally, sgRNAs that focus Cas9
to functional domains provide a greater probability of phenotypic
impact, likely because in-frame mutations in these regions have
a greater potential to disrupt protein function (Shi et al., 2015).
The implementation of optimized effector expression strate-
gies should also drive the efficacy of CRISPR knockout assays.
Systems have been developed in which multiple RNA polymer-
ase III promoters drive independent sgRNAs (Vidigal and Ven-
tura, 2015). Alternatively, others have shown that Cpf1 can be
focused to multiple targets in cells that express crRNA arrays
harboring independent sgRNAs (Zetsche et al., 2017). These
tools have primarily been applied in order to characterize combi-
natorial gene interactions and to delete non-coding sequences.
However, these strategies may also aid in studies where single
gene knockouts are desired in each cell, as the simultaneous
focusing of Cas9 to multiple sites within the target should elicit
greater functional consequences.
DESIGN
Not all of the strategies outlined above have been experimen-
tally validated, nor have they been integrated into a consoli-
dated framework for constructing sgRNA expression vectors.
We reasoned that a gain in sgRNA efficacy could be achieved
by combining current selection methods with strategies to maxi-
mize the likelihood of functionally deleterious genomic scars. We
developed an sgRNA selection algorithm that identifies puta-
tive targetsbasedonpredictive nucleotidecombinations, the like-
lihood of an FSM, and whether the target lies in a functional
domain. For effector delivery, we have developed a system that
allows for the simultaneous expression of two independent
sgRNAs from each construct. With the goal of expressing twoublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
guides for a single target in each construct, we have developed a
computational algorithm that optimizes the likelihood of synergis-
tic deleterious effects. These methods have been validated
through a reanalysis of pre-existing data and by carrying out
comparative multiplexed CRISPR screens. We have predicted
construct designs for all protein-coding human genes and made
these available via a web portal (http://croatan.hannonlab.org/).
RESULTS
gRNA Selection Strategy
Two datasets of sgRNA efficacy have been used to develop exist-
ing selection algorithms. Doench et al. (2014) assessed the
potency of sgRNAs in libraries that tiled cell surface proteins.
There the abundance of integrated sgRNAs in FACS-isolated,
target-negative cells was used as a measure of effector strength.
Chari et al. (2015) infected cells with scrambled Cas9 targets and
then transfected the samecellswith corresponding sgRNAs. Here
target mutation rates were the readout for efficiency. We devel-
oped a random-forest-based sgRNA prediction tool using these
two datasets for training. For each dataset, ten random forests
were trained to separate potent andweakguides,whichwerepre-
classified based upon a top- and bottom-40% efficacy cutoff,
respectively. All 3mers in the region spanning four nucleotides up-
streamand six nucleotides downstreamof the sgRNAbinding site
were used as input. The ten random forests were trained using
incrementally increasing penalties for false-positive predictions.
Thus, those trained with higher values were more stringent in as-
signing potency to a target. When analyzing new sgRNAs, se-
quences receive scores equal to the highest stringency level
they pass in both random forest sets. This scoring system was
applied to sgRNAs in the Doench tiling set that were withheld dur-
ing training, and a significant difference in efficacy is observed
when comparing sgRNAs that pass versus those that fail the min-
imum-stringency threshold (Figure S1A, rank-sump value < 0.01).
Beyond this, increments in prediction values are notmatchedwith
significant efficiency gains, although scores do correlate with po-
tency globally.
The advantage of focusing Cas9 to known functional protein
domains has been previously recognized (Shi et al., 2015). How-
ever, as many genes lack well-defined domain information, this
strategy is not easily applied to the construction of genome-scale
sgRNA collections. As a surrogate, we used amino-acid conser-
vationat theCas9cut-site toguidesgRNAselection.Weassigned
scores to targets based on the predicted deleterious effects of
DSB-proximal amino acid substitutions, which were calculated
using the protein variation effect analyzer (PROVEAN) algorithm
(Figure S1B; Choi et al., 2012). A reanalysis of the Doench tiling
set shows that, for sgRNAs that pass theminimum random forest
stringency threshold, these scores are correlated with the proba-
bility of inducing a measurable phenotype (Figure 1A, Spearman
correlation [r] = 0.32).
Others have demonstrated that repair at Cas9-induced DSBs
is partially driven by HEJ (Figure S1C; Bae et al., 2014). Using
deep-sequencing data of Cas9 targets, we developed a linear
regression model to predict the likelihood of homology-guided
repair resolutions based on the length, GC content, and dis-
tance to the DSB of the corresponding homologous loci. Theoverall likelihood of an FSM at a target is measured as the frac-
tion of predicted resolution scores that correspond to FSMs
(Figure S1D, r = 0.74). This is only relevant for targets where ho-
mologous repair is likely. Thus, a lower-limit cutoff equal to the
median of likelihood sums for HEJ-guided resolutions at human
CDS Cas9 targets is applied as well. A reanalysis of the Doench
dataset demonstrates that, for sgRNAs that pass the minimum
random forest stringency threshold, a gain in efficacy can be at-
tained by selecting targets where there is >66% chance that an
FSM will occur (Figure 1B, rank-sum p value < 0.05).
To consolidate these predictive component algorithms, we
first group sgRNAs based on the stringency level they passed
during random-forest analysis (groups A, B, and C, Figure S1E).
Within each group, sgRNAs are ranked based on their passing
conservation and FSM-likelihood threshold tests. The median
score of all human CDS Cas9 sites is the lower-limit threshold
for conservation. We set a threshold of 66% to qualify sgRNAs
as being likely to induce an FSM. sgRNAs in group A are given
a score between one and three based on their passing zero,
one, or two of the conservation and FSM-likelihood tests.
With these same tests, sgRNAs in groups B and C are assigned
scores between four and six and between seven and nine,
respectively. A reanalysis of the Doench tiling set with this
algorithm, which we call CRoatan, demonstrates that scores
correlate strongly with potency (Figure 1C, r = 0.52). When
CRoatan was applied to identify ten sgRNAs for each protein-
coding gene in the refseq annotation, the algorithm could identify
high-scoring sgRNAs for each target (Figure S1F).
To evaluate CRoatan empirically, we constructed four CRISPR
librarieswhoseoutputwould informon thequality of the tool. Each
library was composed of 200 sgRNAs targeting 20 essential and
20 nonessential genes (EG and NEG, respectively; five sgRNAs
per gene). EGs were identified in a summary analysis of indepen-
dent shRNA screens, and olfactory-receptor genes served as
NEGs (Marcotte et al., 2012). For each library, a different sgRNA
selection tool was used to define inclusion: gene perturbation
platform (GPP; Doench et al., 2014), sgRNAScorer (Chari et al.,
2015), Edit-R (Dharmacon), and CRoatan. Libraries were cloned
into a lentiviral backbone where human U6 drives sgRNA expres-
sion and where a zsGreen-P2A-Puromycin bicistronic transcript
is expressed from the spleen focus-forming virus promoter
(SFFV). Libraries were packaged and infected into A-375 mela-
noma and K-562 leukemia cells, and following selection with pu-
romycin, the cells were passaged for12 doublings. Normalized
log ratioswere then calculatedbasedonconstruct abundances in
the infected and final cell populations (Knott et al., 2014).
To assess the effectiveness of our effector selection strate-
gies, we calculated gene-normalized depletion scores for all
EG-sgRNAs in the CRoatan library. We could not test the initial
grouping strategy, as all sgRNAs were group C members (Fig-
ure S1E). The depletion rates of EG-sgRNAs were correlated
with CRoatan score (Figure 1D, r = 0.52). Depletion rates
were not found to correlate with conservation or FSM-likeli-
hood scores alone. When EG-sgRNA depletion rates were
compared among the four libraries, CRoatan sgRNAs were
found to be significantly more reduced in representation than
those identified with the sgRNAScorer and Edit-R tools (Fig-
ure 1E, rank-sum p value < 0.05). CRoatan EG-sgRNAs wereMolecular Cell 67, 348–354, July 20, 2017 349
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Figure 1. CRoatan, an Algorithm for Identi-
fying Potent sgRNAs
(A) Thepotencyof sgRNAsanalyzed inDoenchetal.
stratified by conservation score (calculated as
described in Figure S1B, r = 0.32). An sgRNA
percentile is thepercentile rankof ansgRNA relative
to all other effectors targeting the same gene. This
plot, as all others in the figure, was generated with
the MATLAB boxplot function using default
parameters. The edges of the box are the 25th and
75th percentiles. The error bars extend to the values
q3+w(q3q1) andq1w(q3q1),wherew is 1.5
and q1 and q3 are the 25th and 75th percentiles.
(B) Efficacy percentiles of the sgRNAs analyzed in
Doench et al. when stratified by the likelihood of
frameshift mutations (FSM likelihood) at the cor-
responding target site (rank-sum p value = 0.0405
for tertile 3 versus tertile 1 and 2 sgRNAs).
(C) Efficacy percentiles of the sgRNAs analyzed in
Doench et al. when stratified by the consolidated
CRoatan algorithm (r = 0.52).
(D) Z-score-normalized depletion rates of EG-
sgRNAswhen stratified byCRoatan score (r= 0.21).
Depletion rates were calculated as the average log
ratio in screens carried out in A-375 and K-562 cells.
(E) Depletion rates of NEG- and EG-targeting
sgRNAs in screens corresponding to those
described in (D). sgRNA libraries were designed
using the GPP-WP, sgRNAScorer, and Edit-R al-
gorithms (rank-sum p value = 0.0942 for GPP-WP,
0.0209 for sgRNAScorer, and 0.0233 for Edit-R).more depleted than those identified with the GPP algorithm;
however, this difference was not statistically significant (rank-
sum p value > 0.05).
Dual-sgRNA Expression Constructs
We reasoned that a higher frequency of deleterious mutations
could be inflicted by simultaneously focusing multiple inde-
pendent sgRNAs to each gene target. Toward this end, we
constructed a lentiviral vector harboring two divergent U6 pro-
moters, where the 50 promoter was human and the 30 promoter
was chicken (Figure 2A, hU6 and cU6, respectively). These
were chosen to reduce the probability that recombination
would eliminate critical elements of the cassette. Between the
promoters is an identification barcode, which is bordered by350 Molecular Cell 67, 348–354, July 20, 2017Illumina adapters, for sequencing-based
quantification of construct abundances.
The vector also harbors a bicistronic
zsGreen-P2A-Puromycin transcript that
is expressed from SFFV.
We designed an algorithm to pair
sgRNAs for a target within the dual-U6
vector to maximize the probability of
synergistic deleterious effects. The algo-
rithm receives as input ten sgRNAs,which
have been extracted from the top-20
CRoatan-scoring effectors, after they
have been reranked to reflect off-target
likelihoods (Figure 2B; Knott et al., 2014).A10310pairwise scorematrix is thencalculatedusingaheuristic
scoring algorithm (Figure S2A). sgRNAs with overlapping targets
are not considered for pairing. To ensure that each construct har-
bors at least one potent effector, the algorithm increments the
score of sgRNA pairs with unbalanced CRoatan scores. sgRNA
pairs are also increased in their scores if they target the same
exon or two exons that contribute to a common set of isoforms.
Finally, we predicted that DSB-DSB blunt-end joining would be
the predominant repair resolution in cases where simultaneous
cleavage events caused the target-flanked region to be deleted.
Thus, the score is also increased for each pair whose deletion
fragment length corresponds to an FSM. After the sgRNA pairs
have been scored, a weighted maximum matching algorithm is
applied to identify thecouplingwith thehighest sumofpair scores.
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Figure 2. Simultaneous Targeting with
Multiple sgRNAs Results in Predictable
Genomic Scars
(A) Schematic map of the lentiviral, dual-sgRNA
expression vector with relevant features high-
lighted. hU6, human U6 promoter; cU6, chicken
U6 promoter; hsgRNA, human U6-promoter-
driven sgRNA; csgRNA, human U6-promoter-
driven sgRNA; HTS, high-throughput sequencing
adapters; SFFV, spleen focus-forming virus
promoter.
(B) sgRNA pairing algorithm used to design five
targeting constructs for a gene. The top 20 sgRNAs
for each gene are filtered to a set of 10 to reduce the
probability ofoff-targetingeffects.Pairswithin these
10are thenscoredusing thesetofheuristicsdefined
in Figure S2. The resultant pairing matrix is then
used as input for a maximum-weighted matching
algorithm to define a final set of 5 sgRNA pairs.
(C) Paired-end sequencing analysis of genomic
scars left after dual-CRoatan NEG-targeting con-
structs have been infected into A-375 and K-562
cells. hsgRNA and csgRNA indels are where only
one of the two targeted regions shows mutational
burden in an HTS fragment. hsgRNA and csgRNA
indel counts represent cases where both targets
have indels, and fragment deletions are where the
region between the two targets is deleted.
(D) Analysis of the genomic scars described in (C)
that correspond to fragment deletions between
two sgRNA target sites. The top ten most frequent
deletions are shown with their corresponding rate
of occurrence, as measured by their average fre-
quency in infected A-375 and K-562 cells. Scars
that result from exact deletion of the double-
strand-break-flanked fragment are annotated as
DSB-DSB deletions. Scars where, in addition to
the fragment deletion, other bases are inserted or
deleted are annotated as non-DSB-DSBdeletions.To test our library assembly strategy, we cloned dual-CRoatan
constructs for three olfactory receptor genes (OR10A4, OR2W5,
and OR6C74) and infected A-375 and K-562 cells with these.
These sgRNA pairs were chosen for the short distance between
their corresponding targets, which allows simultaneous analysis
of both sites with Illumina paired-end sequencing. We profiled
the genomic scars that had been left after infection and found
that high rates ofmutation existed for all sgRNA pairs (Figure 2C).
Fragment deletion between the two targets was the predominant
scar. A deeper analysis revealed that, in these cases, the most
commonly observed resolution was the predicted blunt-end
joining of the two DSBs (Figures 2D and S2B).
High-Throughput Analysis of Library Efficacy
To evaluate our strategymore broadly,we designeda combinato-
rial CRISPR screening library whose output would inform on the
contributions that the CRoatan algorithm, as well as the dual-MolsgRNA expression system, made to re-
agent efficacy. The library was composed
of 100 sgRNAs targeting 20 EGs and 20
NEGs. sgRNAs were cloned into both thehU6 and cU6 positions, which resulted in a final library harboring
10,000sgRNApairs. The constructswere screened inA-375 cells,
and these experiments were processed in the same manner as
those experiments described in Figures 1D and 1E.
Toassess the impact of theCRoatanalgorithmconstituents,we
calculated gene-normalized depletion scores for constructs
harboring one EG-sgRNA, as depletion rates could be attributed
directly to the efficacy of this effector for these constructs. In
contrast to the single-sgRNA CRoatan screen described in Fig-
ures 1D and 1E, here depletion rates were significantly greater
for EG-sgRNAs that passed the conservation and FSM-likelihood
thresholds, indicating that these two strategies contributed posi-
tively (Figures S3A and S3B, Friedman p value < 0.05). We reason
that this correlation was observable here, and not in the initial
CRoatan screen, because for each EG-sgRNA, the score was
calculated as the average depletion rate of the 100 constructs in
which it was paired with an NEG-sgRNA. Also, as was the caseecular Cell 67, 348–354, July 20, 2017 351
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Figure 3. Dual-CRoatan Constructs Provide Superior CRISPR-Based Gene Targeting
(A) Average depletion rates for each EG-sgRNA when it is paired with NEG-sgRNAs (gray) and when it is paired with sgRNAs targeting the same EG (brown).
sgRNAs are grouped based on the gene target; rank-sum p value = 0.0006.
(B)Depletion rates ofNEG-andEG-targetingCRISPRconstructs innegative-selection screens. Shownare theconsolidateddepletion rates for single-sgRNAconstructs
selected using pre-existing tools (GPP, sgRNAScorer, or Edit-R algorithms) as well as the rates for CRoatan single-sgRNA constructs and CRoatan dual-sgRNA con-
structs (dual-CRoatan, rank-sumpvalue=2.5e-5 for existingalgorithmsandpvalue>0.05 for single-CRoatanconstructs).Depletion rateswerecalculatedas theaverage
log ratio inscreenscarriedout inA-375andK-562cells. Thisplotwasgeneratedwith theMATLABboxplot functionusingdefaultparameters. Theedgesof theboxare the
25th and 75th percentiles. The error bars extend to the values q3 + w(q3 q1) and q1 w(q3 q1), where w is 1.5 and q1 and q3 are the 25th and 75th percentiles.
(C) Gene-level analysis of CRoatan and CRoatan dual-sgRNA construct depletion rates. Using the average depletion rate for each construct in A-375 and K-562
cells, gene ‘‘hits’’ were calculated using a series of stringencies (top 10%, 20%, 30%, 40%, and 50% most-depleted sgRNAs). For a gene to be called a hit at a
given stringency, a minimum of two constructs need to be depleted beyond the stringency level.for the initial CRoatan screen, depletion rates correlated positively
with CRoatan score (Figure S3C, Friedman p value < 0.01).
A significant increase in depletion levels was also observed
when constructs harboring two EG-sgRNAs were compared to352 Molecular Cell 67, 348–354, July 20, 2017those harboring one or zero EG-RNAs (Figure S3D, rank-sum p
value < 0.01). This was also evident at the individual sgRNA level.
For each EG-sgRNA, we calculated the mean depletion rate of
constructs where it was paired with an NEG-sgRNA and also
where it was paired with one of the other four sgRNAs that target
the same gene. Nearly all of the EG-sgRNAs elicited a more
robust phenotype when they were paired with other sgRNAs tar-
geting the same gene (Figure 3A, rank-sum p value < 0.001).
As a final test of our consolidated strategy, we constructed
a CRISPR library using the CRoatan algorithm and the pairing
principles outlined in Figures 2A, 2B, and S2A (dual-CRoatan).
Each construct in the library harbors two sgRNAs that together
target one of the 10 EGs or 10 NEGs described in Figures 1D
and 1E for multiplexed mutagenesis. The library was screened
and analyzed as was described for these earlier experiments.
The EG-targeting dual-CRoatan constructs had significantly
higher depletion rates than the single-sgRNA constructs. This
was true when all sgRNAs identified with existing algorithms
were considered together and also when sgRNAs identified
with the GPP, sgRNAScorer, and Edit-R algorithms were con-
sidered separately (rank-sum p values = 2.4e-5, 0.005, 3.9e-5,
and 0.002, respectively). EG-targeting constructs in the dual-
CRoatan library were more depleted than their counterparts
in the CRoatan library; however, this difference was deemed
statistically insignificant (rank-sum p value > 0.05). Finally, we
analyzed the CRoatan and dual-CRoatan screens to identify
gene-level ‘‘hits.’’ Using a two-construct minimum threshold
to identify a gene as depleted, we calculated false-positive
and true-positive rates at a series of construct depletion cut-
offs. This analysis demonstrated the superiority of the dual-
CRoatan library in terms of both sensitivity and specificity
(Figure 3C).
DISCUSSION
The CRISPR-Cas9 system has been applied to a variety of
molecular manipulations, with the most common being pertur-
bation of gene function inmammalian cells. This can be achieved
by inducing mutations in target gene coding sequences or
by focusing transcriptional regulators to gene promoters. Others
have demonstrated, through a set of parallel loss-of-func-
tion screens, that mutagenesis is more effective at ablating
gene function. Here we have combined machine-learning and
sgRNA-expression strategies to create CRISPR constructs that
maximize the likelihood of mutation-based functional silencing.
Through a set of parallel genetic screens, we have demonstrated
that these reagents are significantly more efficacious than other
available tools. Based upon these results, we have assembled a
sequence-verified collection of CRISPR constructs using these
design principles.
We have demonstrated that a significant gain in efficacy is
attained when two independent sgRNAs simultaneously focus
Cas9 to the target gene. Thus, we have designed the library
such that two sgRNAswith high prediction scores are expressed
from each construct (Figure S3E). An added benefit of this strat-
egy is that constructs can be easily manipulated to target gene
pairs to interrogate synthetic interactions. This feature will be
particularly useful for identifying parallel or related molecular
pathwayswith combinatorial screens. Another feature of the tool-
kit is the availability of individual sequence-verified constructs,
which allows large-scale screens to be carried out in an arrayed
format.Overall, we hope that this toolkit will be of benefit to the scien-
tific community, as it will allow individual and combinatorial gene
knockouts to be carried out on a large scale in both multiplexed
and arrayed formats. The library design includes five constructs
for each protein coding human Refseq gene. At present, the
library is comprised of 50,000 sequence-verified constructs;
the goal is to complete the collection at five constructs per
20,000 predicted genes.LIMITATIONS
At the date of publication, half of the100,000 construct designs
in the human library had been sequence verified and included in
the physical resource. Thus, there is poor coverage, in terms of
targetingmolecules, for a subset of genes. Current coverage sta-
tistics are reported on the following web portal: http://croatan.
hannonlab.org.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILSB Cell Lines
d METHOD DETAILS
B Random Forest Training and Scoring
B sgRNA-Pair Scoring
B sgRNA Library Construction
B sgRNA Library Screening
B CRISPR/Cas9 Library Processing and Analysis
B Dual-sgRNA Genomic Scar Analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND SOFTWARE AVAILABILITY
d ADDITIONAL RESOURCES
B Detailed Protocol
B Online ResourceSUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, three tables, and supple-
mental text and can be found with this article online at http://dx.doi.org/10.
1016/j.molcel.2017.06.030.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
CRISPR/Cas9 screens were performed in melanoma A-375 (ATCC CRL-1619, female) and chronic myelogenous leukemia K-562
(ATCC CCL-243, female) cell lines. A-375 were grown at 37C in DMEM, supplemented with 10% FBS and penicillin/streptomycin.
K-562 were grown at 37C in RPMI1640 supplemented with 10% FBS and penicillin/streptomycin. The 293FT cell line (Thermo-
Fischer) was grown at 37C in DMEM supplemented with 10% FBS and penicillin/streptomycin.
A-375 cells were infected at lowMOI by virus produced using lentiCas9-Blast (Addgene #52962) (Sanjana et al., 2014) and selected
using blasticidin (10 mg/mL). Following 10 days of selection, single cells were sorted using the FACSAria IIU cell sorter (BD
Biosciences) into 96-well plates. 10 A-375-Cas9 clones were tested for Cas9 functionality by infection with a vector expressing
ZsGreen and an sgRNA targeting ZsGreen. Knockout efficiency was estimated by flow cytometry after 14 days. One of the
A-375-Cas9 clonal lines exhibiting more than 50% knockout of ZsGreen in this assay was selected for further experiments. The
K-562 clonal cell line expressing Cas9 was kindly gifted by Dr. Vakoc (Cold Spring Harbor Laboratory).Molecular Cell 67, 348–354.e1–e3, July 20, 2017 e1
METHOD DETAILS
Random Forest Training and Scoring
Ten random forests were constructed for each of the Doench et al. and Chari et al. datasets. For each data type, sgRNAs in the top-
and bottom-40th percentile for each gene were classified as potent and weak, respectively. The 10 forests were trained using the
MATLAB treeBagger package (1000 trees per forest). Forests were trained using incrementally increasing penalties for false-positive
classifications (0.2, 0.4, 0.6, 0.8, 1, 1.2, 1.4, 1.6, 1.8, 2). During training forests are constructed using the 28 overlapping 3mers of each
target as features, and the class of the target (potent or weak) as the output.
When a new target is being scored, it is decomposed into 28 3mers, and these are given to each of the 20 forests (10 corresponding
to the Doench et al. data and 10 to the Chari et al. data) as input. The target is then assigned a value between 0 and 10 corresponding
to the highest stringency forest it was assigned as potent by. For example, if a target was called potent by a Doench forest that was
trained with a penalty of 1.2 (6th lowest) and a Chari forest trained with a penalty of 1 (5th lowest), the target would receive a score of 5.
The data presented in Figures S1A and 1C were calculated using out-of-bag random forest predictions with default MATLAB
parameters.
sgRNA-Pair Scoring
For each gene, all pairwise scores were calculated for the top 10 CRoatan scoring sgRNAs. All sgRNA pairs begin with a score of 0.
Overlapping pairs are assigned a final score of 0. Pairs that are less than 10kb apart with DSB-DSB distances that are not divisible by
3 are assigned a score of 2.5 if they target the same transcripts. Scores are incremented by 1 if pairs have imbalanced CRoatan
scores (one less than 7 and one greater than 7). This scoring matrix is then given as input to the maximum weighted matching algo-
rithm (MATLAB maxWeightMatching).
sgRNA Library Construction
For single sgRNA libraries, sgRNA sequences were predicted using existing algorithms (Edit-R, sgRNAScorer, GPP web portal and
CRoatan) and oligonucleotides containing these sequences were ordered from Integrated DNA Technologies (IDT, Table S1). These
molecules were amplified by PCR (forward primer (FP): TTACCGTAACTTGAAAGTATTTCGATTTCTTGGCTTTATATATCTTGTGGA
AAGGACGAAACACCG, reverse primer (RP): GGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC) and cloned by Gibson
assembly into a 3rd generation lentiviral vector harboring a U6 promoter, an sgRNA backbone, and a ZsGreen-P2A-PuromycrinR
transcript driven by a spleen focus-forming virus promoter (pCRoatan-singleSgRNA).
For dual sgRNA libraries, sgRNA sequences were predicted using CRoatan. Primers containing these sequences were ordered
from IDT (Table S1) and used to amplify a hU6-EM7-ZeocinR-cU6 cassette (pCRoatan-dualPromoter). The amplicon was digested
with BbsI (NEB) and ligated into a 3rd generation lentiviral vector (pCRoatan-dualSgRNA) previously digested with BsmBI
(ThermoFischer).
Combinatorial sgRNA libraries were built using DNA chips (CustomArray, Inc.) containing 10K molecules harboring a barcode and
two flanking sgRNA sequences (Table S2). Chips were amplified by 5 separate 18-cycle PCRs to ensure high-complexity end
product. The amplicons were first cloned by ligation into an intermediate cloning vector (pCR-BluntII TOPO based) using SpeI
(NEB) and ApaI (NEB). Subsequently, the hU6 and cU6 promoters driving the sgRNAs were added to the vector. The hU6 promoter
was amplified from lentiCrisprv2 (Addgene #52961) by PCR (FP: AGTACCGTCTCTGGTGTTTCGTCCTTTCCACAAG, RP: GTACCT
ACGCGTGAGGGCCTATTTCCCATGATTC), and cloned by ligation using the BsmBI (ThermoFischer) and MluI (NEB) restriction
sites. The cU6 promoter (cU6-3, Kudo and Sutou, 2005) was amplified from a gBlock (IDT) by PCR (FP: ATCGATCTCGAGG
CGCCGCCGCTCCTTCAGGCA, RP: TGATCCTGGTCTCACGACTAAGAGCATCGAGACTGC), and cloned by ligation using the
BsaI (NEB) and XhoI (NEB) restriction sites. Following these three steps, the full sgRNA1-hU6-EM7-ZeocinR-Barcode-cU6-sgRNA2
cassette was digested from the intermediate cloning vector using BbsI and ligated in the lentiviral expression vector (pCRoatan-dual-
SgRNA) as described previously. All transformations were performed with Invitrogen’s MegaX DH10B T1 electro-competent cells
using a Bio-Rad Gene Pulser Xcell and Bio-Rad Gene Pulser 1 mm cuvettes for electroporation. For each library, a minimum of
10 million successfully transformed cells were obtained.
sgRNA Library Screening
sgRNA libraries were packaged using the 293FT cell line (Thermo Fischer). Cells were co-transfected with library vector (60 mg),
pMDL (12.5 mg), CMV-Rev (6.5 mg) and VSV-G (9 mg) by calcium phosphate transfection. The media was replaced at 14h and
virus was collected at 36h and filtered using a 0.45 mM syringe filter (Millex-HV, EMD Millipore). Viral infections were per-
formed at an MOI of 0.3 to ensure a maximum of one sgRNA integration per cell. sgRNA representation in the infected popu-
lation was maintained at a minimum of 1000 infected cells per sgRNA at each passage. All screens were performed in tripli-
cates. Two days after infection, cells were collected for a reference time point. After 12 doublings, cells were harvested
for a final time point. Infected cells were selected using Puromycin (1 mg/mL) after the initial time point and throughout the
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CRISPR/Cas9 Library Processing and Analysis
Following cell harvests, DNA was extracted using the QIAGEN QIAamp DNA Blood Midi kit. For each sample, sgRNA molecules or
barcodes identifying sgRNA pairs were extracted from the genomic DNA in 24 separate 30-cycle PCR reactions in which 2 mg of DNA
input was included. Illumina adapters were included in the PCR primers (Table S3). Libraries were sequenced using custom read one
primers on the Illumina MiSeq or HiSeq platforms. Following sequencing, reads were trimmed to a length of 20bp and construct
counts were extracted using the bowtie algorithm (Langmead et al., 2009). Constructs were then filtered based on a minimum
read-count threshold of 50 in the reference sample. Corresponding log-fold change valueswere then calculated by dividing the abun-
dance after twelve doublings by the abundance at the reference time point, two days after infection (Knott et al., 2014).
Dual-sgRNA Genomic Scar Analysis
200,000 A-375-Cas9 and K-562-Cas9 cells were transduced with CRoatan constructs targeting 3 different olfactory receptor genes.
Following selection with Puromycin cells were grown for12 doublings and then harvested for analysis. DNAwas extracted using the
QIAGEN QIAamp DNA Blood Midi kit. The target region, including 50bp upstream and downstream of both sgRNA target sites was
amplified by PCR, in 16 25-cycle PCR reactions in which 500ng of DNA input was included (Table S3). Following purification using the
QIAquick PCR Purification Kit, Illumina adapters were added via PCR and samples were processed on the Illumina MiSeq platform
using paired-end reads of 200bp to cover both sgRNA target sites. Readsweremapped to the relevant genomic region using the bwa
mem algorithm and cut types were analyzed and counted using the CIGAR string of the alignment (Li and Durbin, 2009).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters such as definition of center, error bars and significance are reported in the main text, figures and figure leg-
ends. Data are judged to be significant when p < 0.05 by the rank-sum test or the Friedman test. Statistical significance analysis
was performed in MATLAB using the freidman and ranksum functions.
DATA AND SOFTWARE AVAILABILITY
All raw and processed data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus
under accession number GSE97434. All code will be made available for non-commercial use upon request.
ADDITIONAL RESOURCES
Detailed Protocol
A detailed protocol describing the cloning of pairs of sgRNAs in the pCRoatan-dualSgRNA expression vector is provided in the
Methods S1.
Online Resource
Detailed cloning protocols, plasmid maps and construct designs for all protein coding human genes are available via a web portal:
http://croatan.hannonlab.org.Molecular Cell 67, 348–354.e1–e3, July 20, 2017 e3
